Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit is currently disabled

Tess Ann O'Meara, M.D.

Concepts (75)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunoconjugates120259750.550 Why?
Exosomes120194170.480 Why?
Breast Neoplasms62025211780.270 Why?
Tumor Microenvironment2202139440.270 Why?
MicroRNAs1201937920.220 Why?
Camptothecin120255990.180 Why?
Ketones120211830.180 Why?
Furans120211990.170 Why?
AIDS Dementia Complex120181540.150 Why?
Isoenzymes1202216880.140 Why?
Anesthesia, Local120192770.140 Why?
Lymphocytes, Tumor-Infiltrating2202111050.140 Why?
Gait Disorders, Neurologic120182430.130 Why?
Genomics3202159240.120 Why?
Receptors, Estrogen2202122520.120 Why?
Urinary Incontinence120184900.110 Why?
HIV Infections12019175420.110 Why?
Nerve Block120197170.100 Why?
Anesthesia, General1201911880.100 Why?
Antineoplastic Combined Chemotherapy Protocols22025118720.100 Why?
Drug Resistance, Neoplasm2202553320.100 Why?
Germ-Line Mutation1202018850.100 Why?
Lower Extremity1201912170.090 Why?
Vascular Surgical Procedures1201915060.090 Why?
Neoplasm Staging32019112170.080 Why?
Drug Therapy, Combination1201963100.080 Why?
Population Surveillance1201925940.080 Why?
Peripheral Arterial Disease1201913040.070 Why?
Neuropsychological Tests1201971210.070 Why?
Gene Expression Profiling2202195320.070 Why?
Endovascular Procedures1201922150.060 Why?
Anti-HIV Agents1201945670.050 Why?
Female920253966600.050 Why?
Gene Expression Regulation, Neoplastic1201986280.050 Why?
Signal Transduction32021236210.050 Why?
Humans1320257670400.050 Why?
Neoplasm Recurrence, Local1201994100.040 Why?
Middle Aged520212232330.040 Why?
Neoplasm Metastasis2202148920.040 Why?
Cross-Sectional Studies12019263250.040 Why?
Prognosis12019299630.040 Why?
Genetic Heterogeneity120217350.040 Why?
Open Reading Frames120208180.030 Why?
Receptors, Progesterone1202111590.030 Why?
Epigenomics120229590.030 Why?
Antigen Presentation1202112500.030 Why?
Aged420211713190.030 Why?
Estrogens1202115360.030 Why?
Kinetics1202262870.030 Why?
Germ Cells120186440.030 Why?
Adult420212233170.030 Why?
Neoplasms12020223500.020 Why?
Treatment Outcome32021652950.020 Why?
Disease-Free Survival1201968440.020 Why?
Genome, Human1202144410.020 Why?
Epigenesis, Genetic1202238280.020 Why?
DNA Methylation1202244260.020 Why?
Time Factors22019401540.020 Why?
Disease Management1201825310.020 Why?
Survival Rate12021128230.020 Why?
Mutation22022302110.020 Why?
Male320193642030.020 Why?
Patient Selection1201942560.020 Why?
Cytokines1202174460.020 Why?
Cell Line, Tumor12022170970.020 Why?
Aged, 80 and over22020595480.010 Why?
Case-Control Studies12021222540.010 Why?
Age Factors12020184010.010 Why?
Aging1202287290.010 Why?
Clinical Trials as Topic1201880480.010 Why?
Risk Factors22019748860.010 Why?
Disease Progression12019136460.010 Why?
Risk Assessment12019242990.010 Why?
Postoperative Complications12019158240.010 Why?
Retrospective Studies12019816590.010 Why?
O'Meara's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (75)
Explore
_
Co-Authors (22)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.